MetaCap

Citius Oncology Statistics

NASDAQ: CTORHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5035-0.0619 (-10.95%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Citius Oncology by the numbers

Citius Oncology has a market capitalization of $53.2 million based on 105.76M shares outstanding. With trailing EPS of $-0.48, Citius Oncology is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.2% below its 50-day average and 36.5% below its 200-day average.

Average daily trading volume is 114.02K shares, or about $57,407 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CTOR valuation vs. peer median

CTOR compared with the median of 8 peer companies
MetricCTORPeer medianDifference
Market cap$53.25M$52.69M+1%
Avg. volume114.02K89.91K+27%

Peer median across 8 companies: LFVN, XBIT, XLO, ALDX, CLNN, BOLD, AZR, ACRV.

Valuation

Price and trading

Previous close
0.5654
Open
0.5698
Day range
0.502 – 0.5698
52-week range
0.491 – 1.83
52-week change
-55.44%
Beta
—
Volume
52.63K

Dividends and events

Annual dividend
None
Next earnings date
Dec 22, 2026

Additional statistics

Market Cap
53.25M
Eps
-0.48
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.83
Week52 Low
0.49
Avg Volume
114.02K
Shares Outstanding
105.76M
Ma50
0.75
Ma200
0.79
Earnings Date
Dec 22, 2026
Pct From52w High
-72.49%
Pct From52w Low
2.55%

Related